Litigation (Opiods)(Narrative) (Details) - 6 months ended Jun. 30, 2026 € in Millions, $ in Millions |
USD ($) |
EUR (€) |
|---|---|---|
| Loss Contingencies [Line Items] | ||
| Maximum damages sought | $ 1,000.0 | |
| Loss contingency accrual | $ 60.0 | |
| Opiod Civil Litigation | ||
| Loss Contingencies [Line Items] | ||
| Potential damages, annual payments, period | 9 years | |
| Loss contingency accrual | $ 281.3 | |
| Opiod Civil Litigation | Minimum | ||
| Loss Contingencies [Line Items] | ||
| Potential damages, annual payments | 27.5 | |
| Opiod Civil Litigation | Maximum | ||
| Loss Contingencies [Line Items] | ||
| Maximum damages sought | 335.0 | |
| Potential damages, annual payments | $ 40.0 | |
| Citalopram Litigation | ||
| Loss Contingencies [Line Items] | ||
| Estimated litigation liability | € | € 12.1 |
| X | ||||||||||
- Definition Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss contingency liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Loss Contingency, Potential Damages, Annual Payments No definition available.
|
| X | ||||||||||
- Definition Loss Contingency, Potential Damages, Annual Payments, Period No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|